MedTrace Logo

Post-transplant Cancer Incidence and Survival in Patients With or Without Pre-transplant Cancer

NCT02491580 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2370

Last updated 2015-07-08

No results posted yet for this study

Summary

Patients with previous malignancies have increasingly been accepted for renal transplantation. However, post-transplant malignancy risk and survival rates of these patients are unknown. Our aim was to assess if previous malignancies pose an unnecessarily high risk of post-transplant malignant tumours and if the organs as a resource are too limited for investment in this patient group.

Conditions

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Principal Investigators

  • Vivan Hellström, MD · Uppsala University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02491580 on ClinicalTrials.gov